Table 3. Geographic distribution and HIV co-infection status of study participants with single defined HSV-2 UL39 genotypes and known geographic origin.

UL39 genotype	Continent				Total N (%)
	North America	South America	Africa	Asia
HSV-2 SD90e/186-like	31	31	45	8	115
HIV co-infected	4	20	29	0	53 (46%)
HIV un-infected	25	11	14	0	50 (44%)
HIV infection status unknown	2	0	2	8	12 (10%)
G19080 long HSV-1 insert	16	16	17	0	49
HIV co-infected	6	11	6	0	23 (49%)
HIV un-infected	10	5	10	0	25 (49%)
HIV infection status unknown	0	0	1	0	1 (2%)
HG52 short HSV-1 insert	4	2	8	0	14
HIV co-infected	0	1	5	0	6 (43%)
HIV un-infected	4	1	3	0	8 (57%)
rare UL39 genotypes	3	0	2	0	5
HIV co-infected	0	0	2	0	2 (40%)
HIV un-infected	3	0	0	0	3 (60%)
total	54	49	72	8	183